Chemoinformaics analysis of THEOBROMINE-MAGNESIUM-OLEATE
| Molecular Weight | 484.924 | nRot | 15 |
| Heavy Atom Molecular Weight | 444.604 | nRig | 2 |
| Exact Molecular Weight | 484.29 | nRing | 2 |
| Solubility: LogS | -5.432 | nHRing | 2 |
| Solubility: LogP | 5.733 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 10 |
| nHA | 8 | APOL | 86.6297 |
| nHD | 0 | BPOL | 49.3003 |
| QED | 0.32 |
| Synth | 2.547 |
| Natural Product Likeliness | 0.618 |
| NR-PPAR-gamma | 0.969 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.737 |
| MDCK | 0.0000173 |
| BBB | 0.123 |
| PPB | 0.984308 |
| VDSS | 0.821 |
| FU | 0.0127639 |
| CYP1A2-inh | 0.446 |
| CYP1A2-sub | 0.181 |
| CYP2c19-inh | 0.455 |
| CYP2c19-sub | 0.078 |
| CYP2c9-inh | 0.405 |
| CYP2c9-sub | 0.987 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.038 |
| CYP3a4-inh | 0.11 |
| CYP3a4-sub | 0.018 |
| CL | 1.857 |
| T12 | 0.303 |
| hERG | 0.135 |
| Ames | 0.005 |
| ROA | 0.02 |
| SkinSen | 0.964 |
| Carcinogencity | 0.133 |
| EI | 0.959 |
| Respiratory | 0.813 |
| NR-Aromatase | 0.049 |
| Antiviral | Yes |
| Prediction | 0.734597 |